Skip to main content

Table 3 Overview of relevant literature in the treatment of Crowe III or IV dysplasia combined with subtrochanteric femoral shortening osteotomy

From: Subtrochanteric shortening osteotomy during cementless total hip arthroplasty in young patients with severe developmental dysplasia of the hip

Study Year Hips (n) DDH type Femoral osteotomy Mean age (Yrs) Stem Type Acetabular Type Clinical results Revision Nonunion Aseptic Loosening Introp fracture Heterotopic ossification Nerve injury Dislocation Survival (end points) FU (Yrs)
Pre-operation Post-operation Act AL Fem AL Introp AF Introp FF
Ozan et al. 2016 32 (25) III&IV Transverse 51 (35–70) Cementless Cementless HHS: 49 (25–72) HHS: 87 (74–94) 2 (6.2%) 0 (0%) 2 (6.2%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 3 (9.3%) 93% (Loosening) 5.1
Verettas et al. 2015 66 (62) III&IV Transverse 46 (24–74) Cementless Cementless NA NA 4 (6%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (1.5%) 2 (3%) 94% (Revision) 9
Sofu et al. 2015 73 (68) III&IV Transverse 47 (31–69) Cementless (Stryker) Cementless (Stryker) HHS: 38.6 ± 2.9 Pain: 16 ± 3.7 HHS: 83.7 ± 6.8 Pain: 40 ± 4.6 6 (8.2%) 4 (5.5%) 0 (0%) 4 (5.5%) 0 (0%) 0 (0%) 2 (2.7%) 0 (0%) 1 (1.3%) 87% (Femoral loosening; nonunion) 5
Desteli et al. 2015 60 (52) III&IV Transverse 51 ± 13 Cementless (HA) Cementless (HA) HHS: 39(25–60) Pain: 3 (1–5) Function: 3(1–5) Motion: 2 (1–4) HHS:93(80–100) Pain: 5.4 (3–6) Function: 4(3–5) Motion: 5 (4–6) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) NA 6.5
Ogawa et al. 2011 6 (6) III&IV Transverse 58 ± 7.2 Cementless (S-ROM) Cementless (Stryker; Depuy) JOA: 35.5 ± 5.7 Pain: 7.0 ± 3.4 Function:9.3 ± 1.3 Motion:11.2 ± 1.3 JOA: 72.3 ± 2.1 Pain: 35.8 ± 1.5 Function:14 ± 0.8 Motion: 16 ± 0.5 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (33.3%) 100% (Loosening) 8.1
Akiyama et al. 2011 15 (11) III&IV Transverse 59 (42–77) Cemented Cemented MAP: 8.1 ± 2.5 MAP: 15.1 ± 1.3 3 (20%) 3 (20%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (13.3%) 80% (Revision) 3–10
Togrul et al. 2010 21 (14) III&IV Transverse 42 (33–52) Cementless Cementless Pain: 2.9 (1–5) Motion: 4.4(3–5) Walking:3.7(2–5) Pain: 5.2 (4–6) Motion:5.4(5–6) Walking:5.5(5–6) 1 (4 .8%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (9.5%) 95% (Revision) 3.4
Howie et al. 2010 35 (28) III&IV Transverse 47 (26–75) Cemented Cemented OHS: 40.2 SF12: 79.6 OHS: 26.7 SF12: 103.3 7 (20%) 2 (3%) 2 (3%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (6%) 3 (9%) 80% (Revision) 5.6
Biant et al. 2009 28 (22) III&IV Transverse 45 (23–74) Cementless (S-ROM) Cementless HHS: 37 (19–69)
SF12: NA WOMAC: 27
HHS:83(44–100) SF12: 95.6 WOMAC: 23 4 (14%) 0 (0%) 2 (7.1%) 0 (0%) 0 (0%) 2 (7.1%) 0 (0%) 1 (3.6%) 0 (0%) NA 10
Park et al. 2007 24 (23) III&IV Transverse 49 (20–66) Cementless Cementless HHS: 35.6 HHS: 81.7 4 (17%) 3 (12%) 1 (4%) 3 (13%) 0 (0%) 3 (13%) 0 (0%) 0 (0%) 1 (4%) 83% (Revision) 4.7
Gotze et al 2007 7 (7) III&IV Transverse 42 (29–64) Cementless Cementless HHS: 43 (29–61) HHS: 77 (66–90) 1 (14%) 0 (0%) 0 (0%) 1 (14%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 86% (Revision) 1.5
Onodera et al. 2006 14 (13) III&IV Transverse 55 (44–69) Cementless Cementless HHS: 38 (15–55) HHS: 82 (35–93) 1 (7%) 1 (7%) 0 (0%) 1 (7%) 0 (0%) 6 (43%) 0 (0%) NA 1 (7%) 93% (Revision) 5
Erdemli et al. 2005 25 (22) III&IV Transverse 44 (28–61) Cementless Cementless HHS: 37 Pain: 2.3 Function: 2.3 Motion: 2.3 HHS: 95 Pain: 5.7 Function: 4.5 Motion: 4.4 4 (16%) 1 (4%) 0 (0%) 2 (8%) 1 (4%) 2 (8%) 1 (4%) 1 (4%) 1 (4%) 84% (Revision) 6
Masonis et al... 2003 11 III&IV Transverse 49 (21–70) Cementless Cementless HHS: 33 (22–45) HHS:74(42–100) 5 (24%) 1 (9%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 76% (Revision) 5.8
  10 III&IV Transverse 49 (21–70) Cemented Cemented     1 (10%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 3 (30%)   5.8
Bruce et al. 2000 9 III&IV Transverse 53 (26–77) Cementless (S-ROM) Cementless HHS: 31 (20–25) HHS: 81 (60–98) 2 (22%) 0 (0%) 0 (0%) 1 (11%) 0 (0%) 2 (22%) 0 (0%) 0 (0%) 1 (11%) 78% (Revision) 4.7
Present study 2016 56 (49) III&IV Transverse 36 (19–45) Cementless (S-ROM) Cementless (S-ROM) HHS: 40 (23–59)
Pain: 2.2 (1–4) Function: 2 (1–3) Motion: 2.3(1–3) PCS: 11.6 (6–17) MCS: 14.4(9–20)
HHS: 87 (77–98) Pain: 5.5 (5–6) Function: 5 (4–6) Motion: 5.2(5–6) PCS: 22 (19–25) MCS: 25 (22–29) 1 (1.8%) 1 (1.8%) 1 (1.8%) 0 (0%) 0 (0%) 3 (5.4%) 2 (3.6%) 3 (5.4%) 3 (5.4%) 98% (Revision) 10.1
  1. LLD length discrepancy, Intraop AF intraoperative acetabular fracture, Intraop FF intraoperative femoral fracture, Acet AL acetabulum aseptic loosening, Fem AL femoral component aseptic loosening, PW polyethylene wear, FNI femoral nerve injury, SNI sciatic nerve injury, OHS oxford hip scores, DVT deep vein thrombosis, PE pulmonary embolism, HHS harris Hip Score, MAP Merle d’Aubigne and Postel, JOA Japanese Orthopaedic Association hip score